Top compounds associated with response to KDR


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.007
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.13 0.007
mRNA RAF265 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.086 0.01
mRNA AZD6244 UHNBreast pan-cancer AAC 0.68 0.01
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.12 0.01
mRNA PD-0325901 CCLE pan-cancer AAC 0.11 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.076 0.02
Download CSV